Responses
Pharmacology and therapeutics
Research
Variation in adverse drug reactions listed in product information for antidepressants and anticonvulsants, between the USA and Europe: a comparison review of paired regulatory documents
Compose a Response to This Article
Other responses
Jump to comment:
- Published on: 14 April 2016
- Published on: 14 April 2016Representation of drug adverse effects in product informationShow More
We strongly endorse the conclusion of Cornelius et al. regarding the necessity for improved communication of benefit-risk information to medication prescribers and users. Based on our extensive experience in evaluation and communication of medication-associated risks, we have previously proposed improvements in the processes for selecting and effectively communicating adverse drug reactions and interactions in HPI (1-3)....
Conflict of Interest:
None declared.